| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 332341 | Psychiatry Research | 2010 | 5 Pages |
The activities of antioxidant defence enzymes were determined in erythrocytes isolated from types I and II schizophrenic male patients and from healthy controls. Significant differences in superoxide dismutase (SOD) activity (type I: 3284 ± 577; type II: 2959 ± 697 compared with controls: 3778 ± 577; analysis of variance (ANOVA) P < 0.001), catalase (CAT) activity (type I: 17.8 ± 1.8 compared to type II: 19.2 ± 1.5 and both compared with controls: 19.2 ± 1.5; ANOVA P < 0.05), glutathione peroxidase (GSH-Px) activity (controls: 17.8 ± 2.3; type I: 13.9 ± 2.9 and type II: 11.6 ± 1.9; ANOVA P < 0.001) as well as in glutathione reductase (GR) activity (controls: 5,0 ± 0.8; type I: 4.3 ± 0.9 and type II: 4.5 ± 0.8; ANOVA P < 0.01) were apparent. Correlation analysis of antioxidant defence enzymes showed significant negative correlation between GSH-Px and CAT activities (P < 0.01) in type I patients. In type II patients, GSH-Px activity was significantly positively correlated with GR (P < 0.01). Canonical discriminant analysis separated type I and type II patients from controls (and among each other) with a high degree of certainty according to the overall group composition of antioxidant defence enzymes. Our results indicate differences in the composition of antioxidant defence between controls and anti-psychotic treated type I and type II patients with a possible negative feedback influence on the pathological process, which could provide a rationale for applying antioxidants during schizophrenic therapy.
